Consonance Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,152,543
| Closed | -$37M | – | 28 |
|
|
2016
Q4 | $37M | Buy |
1,152,543
+396,269
| +52% | +$12.7M | 4.06% | 12 |
|
|
2016
Q3 | $37.8M | Buy |
+756,274
| New | +$37.8M | 3.64% | 13 |
|
|
2016
Q2 | – | Sell |
-746,734
| Closed | -$49.2M | – | 25 |
|
|
2016
Q1 | $49.2M | Buy |
+746,734
| New | +$49.2M | 7.44% | 5 |
|
|
2014
Q4 | – | Sell |
-195,340
| Closed | -$13.5M | – | 27 |
|
|
2014
Q3 | $13.5M | Buy |
+195,340
| New | +$13.5M | 1.85% | 19 |
|